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plasma were extracted with chloroform/methanol mixture 
and subjected to lipid profiling with application of the 
LCMS-QTOF method.
Results We observed a structured plasma lipid response 
among the malaria-infected patients as compared to healthy 
controls, demonstrated by higher levels of a majority of 
plasma lipids with the exception of even-chain length 
lysophosphatidylcholines and triglycerides with lower mass 
and higher saturation of the fatty acid chains. An inverse 
lipid profile relationship was observed when plasma lipids 
were correlated to parasitaemia.
Conclusions This study demonstrates how mapping the 
full physiological lipid response in plasma from malaria-
infected individuals can be used to understand biochemical 
processes during infection. It also gives insights to how the 
levels of these molecules relate to acute immune responses.
Keywords Lipidomics profiling · Malaria · Plasmodium 
falciparum · Triacylglycerides · Lysophosphatidylcholines
Abstract 
Introduction Several studies have observed serum lipid 
changes during malaria infection in humans. All of them 
were focused at analysis of lipoproteins, not specific lipid 
molecules. The aim of our study was to identify novel pat-
terns of lipid species in malaria infected patients using 
lipidomics profiling, to enhance diagnosis of malaria and 
to evaluate biochemical pathways activated during parasite 
infection.
Methods Using a multivariate characterization approach, 
60 samples were representatively selected, 20 from each 
category (mild, severe and controls) of the 690 study par-
ticipants between age of 0.5–6 years. Lipids from patient’s 
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Abbreviations
LCMS-QTOF  Liquid chromatography mass spectros-
copy-quadrupole time of flight
SIRS  Systemic inflammatory response 
syndrome
TAG  Triacylglyceride
VLDL  Very low density lipoproteins
FA  Fatty acids
PCA  Principal component analysis
OPLS  Orthogonal projections to latent structures
LPC  Lysophosphatidylcholine
RSD  Relative standard deviation
1 Introduction
Plasmodium falciparum malaria remains a major global 
health and economic burden in spite of recent intense pre-
ventive measures. Malarial disease entails a complex range 
of parasite-host interactions and a dynamic flow of immune 
responses affecting both organisms. The parasite relies on 
an exchange of metabolites with the human host to ensure 
survival and proliferation (Olszewski et  al. 2009; Kafsack 
and Llinas 2010; Lakshmanan et al. 2011). The host acute 
phase immune response to the parasite carries many com-
mon denominators with other acute infectious and inflam-
matory conditions such as sepsis and systemic inflamma-
tory response syndrome (SIRS) (O’Donnell et al. 2009).
Lipids and lipoprotein metabolism in humans have been 
the focus of intense study and are extensively described in 
many books and reviews (Vance and Vance 2008; Brown 
and Marnett 2011). Recently, emphasis has been put on the 
role of lipoproteins in relation to the immune system, and 
the acute phase response in particular. Feingold et al. estab-
lished that the administration of lipopolysaccharides (LPS) 
increases lipoprotein levels in the peripheral circulation 
(Feingold et  al. 1992). Hyperlipidemia has been described 
to accompany different infectious and inflammatory diseases 
(Gallin et al. 1969; Alvarez and Ramos 1986; Cabana et al. 
1989; Khovidhunkit et al. 2004; Wendel et al. 2007). It is also 
known that hyperlipidaemia in infection arises because of an 
increase of very low density lipoproteins (VLDL) levels due 
to increased de novo fatty acid (FA) synthesis and suppressed 
fatty acid oxidation. This results in increased hepatic produc-
tion of VLDL, suppression of VLDL lipolysis by inhibition 
of lipoprotein lipase and increased adipose tissue lipolysis. 
The proposed mechanisms by which hyperlipidaemia affects 
the immune response to infection involves dissolution of tox-
ins combined with their neutralization and also the immu-
nomodulatory role of lipoproteins (Barcia and Harris 2005; 
Navab et al. 2005). One of the integral components of VLDL, 
cholesterol, is necessary for the internalization of eukaryotic 
pathogens into host cells (Bansal et al. 2005).
Several studies have observed serum lipid changes dur-
ing malaria infection in humans. A meta-analysis study in 
2013 (Visser et  al. 2013) concluded that cholesterol, high 
density lipoproteins (HDL) and low density lipoproteins 
(LDL) concentrations are lower in malaria compared to both 
healthy controls and to other febrile diseases. TAGs were 
shown to be elevated during malaria infection compared to 
healthy controls, but not statistically significant compared to 
symptomatic controls. A recent study reported however that 
lipoprotein levels were specifically perturbed by malaria 
infection as compared to healthy controls, encephalitis and 
sepsis (Sengupta et al. 2016). The clearance of low-level P. 
falciparum infection has also been shown to normalize these 
changes (Faucher et  al. 2002). Although the quantity of 
lipid changes seems to be related to the severity of malaria 
in some studies (Parola et al. 2004; Sengupta et al. 2016), 
others found no correlation (Baptista et al. 1996; Kittl et al. 
1992). Availability of lipoproteins in malaria infection was 
reported to be important for adherence of infected erythro-
cytes to the microvasculature (Frankland et al. 2006, 2007). 
In a recent study we have found increased levels of fatty 
acids in malaria patients compared with controls, which 
could also differentiate between mild and severe cases 
and were positively correlated with parasitaemia values 
(Surowiec et al. 2015). Perturbations in the lipid metabolism 
have also emerged as a defining factor to survival in sepsis 
(Langley et al. 2013). A profound analysis of lipid metab-
olism during malaria infection holds promise for deeper 
understanding of the disease.
Although literature regarding lipid changes connected 
to malaria infection is vast, it has been mainly focused on 
measurement of lipoprotein fractions. There is an extensive 
literature describing lipid analysis using mass spectrom-
etry in malaria in vitro studies (Vo Duy et al. 2012; Botté 
et al. 2013; Gulati et al. 2015; Shears et al. 2017), parasites 
themselves (Maréchal et al. 2011) and in mice models (Itoe 
et al. 2014), but so far no study have described the applica-
tion of lipidomics in malaria to clinical samples. Lipidom-
ics can be described as a global lipid analysis and focuses 
on the identification and relative (untargeted lipidomics) 
or absolute (targeted lipidomics) quantification of all lipid 
species present in biological samples, followed by charac-
terization of samples in relation to the scientific hypothesis. 
Identification of chemical species that could be specifically 
connected to infection can be important not only from the 
point of understanding the pathogenesis and impact on the 
immune response, but also suggest possible avenues of 
treatment.
The aim of the present study was to identify novel patterns 
of lipids in malaria patients using a high resolution approach 
based on lipid-targeted plasma extraction and followed by 
Liquid Chromatography Mass Spectroscopy-Quadrupole 
Time of Flight (LCMS-QTOF) profiling and identification of 
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lipid species. At the same time, we wanted to map the range 
of lipid species in relation to available clinical and personal 
parameters of the patients. We also assessed relation of lev-
els of lipid species to parasitaemia values in order to better 
understand the host response in correlation to incremental 
parasite burden. The expectation was to enhance our knowl-
edge about biochemical processes involving lipid species that 
take place during malaria infection.
2  Materials and methods
2.1  Patients
The research was carried out according to The Code of Eth-
ics of the World Medical Association (Declaration of Hel-
sinki). Ethical clearance was obtained from the Rwanda 
National Ethics Committee RNEC (No: 279/RNEC/2010) 
and the Regional Ethical Committee in Umeå (No: 09-064). 
Written informed consent was provided by the parent 
or legal guardian of each participant. The patients were 
assessed on site by the attending paediatrician/study medical 
officer and biometric and clinical parameters were recorded, 
as listed in Tables S1–S3 and summerized in Table 1. The 
patients were categorized according to the WHO catego-
ries of severe malaria as well as mild malaria (WHO 2010). 
Patients that were treated for malaria, had a known HIV 
positive status or jaundice were excluded from the study. 
This was done to avoid confounding of the metabolic pro-
files that could be related to treatment and both mentioned 
diseases with the malaria profile. Treatment, HIV and jaun-
dice are expected to influence the metabolic plasma profile, 
which in the limited sample set studied would not be pos-
sible to resolve from malaria one. The patients had been fed 
ad libitum before sampling. Blood samples were drawn on 
site and assessment of parasite presence was done in the 
routine lab facilities coupled to each clinic in Rwanda and in 
Sweden of saved Giemsa stained thin blood smears. Twenty 
samples from each group of diagnostic categories were 
selected (healthy controls, mild and severe malaria), ten 
Table 1  Selected clinical and personal parameters of malaria patients included in the study
TR total range; M median; Ind. individual; HC head circumference; MUAC mid-upper arm circumference
Clinical parameter All infected (39 individuals) Mild cases (19 individuals) Severe cases (20 individuals)
Parasitaemia M: 1.9, IQR: 5.4, TR: 0.0-26.6 M: 1.3, IQR: 0.9, TR: 0.2-4.0 M: 6.0, IQR: 9.0, TR: 0-26.6
Age (months) M: 51, IQR: 21, TR: 18–72 M: 48, IQR: 21, TR: 23–72 M: 54, IQR: 25, TR: 18–72
HC (cm) M: 50, IQR: 2, TR: 42–54 M: 50, IQR: 3, TR: 42–54 M: 50, IQR: 4, TR: 45–52
Weight M: 15, IQR: 6, TR: 10–22 M: 15, IQR: 4, TR: 10–22 M: 14.5, IQR: 5, TR: 11–22
Height M: 100, IQR: 13, TR: 44–130 M: 99, IQR: 14, TR: 80–130 M: 101, IQR: 14, TR: 44–115
MUAC (cm) M: 16, IQR: 2.5, TR: 13.5–18 M: 16, IQR: 3, TR: 13.5–18 M: 16, IQR: 2.0, TR: 13.5–17.5
Temperature M: 38.4, IQR: 2, TR: 35.7–40.1 M: 38.3, IQR: 2, TR: 36.3–40.0 M: 38.4, IQR: 2, TR: 35.7–40.1
Systolic pressure M: 100, IQR: 15, TR: 85–120 M: 100, IQR: 20, TR: 85–120 M: 103, IQR: 11, TR: 90–120
Diastolic pressure M: 70, IQR: 20, TR: 50–98 M: 60, IQR: 19, TR: 50–80 M: 75, IQR: 27, TR: 50–98
Pulse rate M: 118, IQR: 44, TR: 72–192 M: 100, IQR: 22, TR: 72–170 M: 139, IQR: 46, TR: 96–192
Breathing rate M: 28, IQR: 12, TR: 20–64 M: 25, IQR: 7, TR: 20–60 M: 30, IQR: 17, TR: 24–64
Haemoglobin M: 10.7, IQR: 2.3, TR: 6.3–13.9 M: 11.1, IQR: 2.7, TR: 7.2–13.2 M: 10.6, IQR: 2.1, TR: 6.3–13.9
Glucose M: 6.2, IQR: 2.5, TR: 1.7–8.1 M: 5.5, IQR: 2.0, TR: 3.6–8.1 M: 6.4, IQR: 1.8, TR: 1.7–7.4
Length of illness (days) M: 2, IQR: 2, TR: 1–6 M: 2, IQR: 2, TR: 1–4 M: 2, IQR: 2, TR: 1–6
Gender 19 females, 20 males 9 females, 10 males 10 females 10 males
Cough 19 positive 9 positive 10 positive
Diarrhea 8 positive 3 positive 5 positive
Breathlessness 6 positive 0 positive 6 positive
Loss of consciousness 3 positive 0 positive 3 positive
Black urine 2 positive 0 positive 2 positive
Convulsions 4 positive 0 positive 4 positive
Illness apart malaria 14 positive 6 positive 8 positive
Prostration 15 positive 0 positive 15 positive
Splenomegaly 4 positive 0 positive 4 positive
Hepatomegaly 7 positive 2 positive 5 positive
Dehydration/dry mucus 7 positive 1 positive 6 positive
Depth of breathing 1: 1 ind.; 2: 12 ind.; 3: 24 ind 1: 1 ind.; 3: 17 ind 2: 12 ind.; 3: 7 ind
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from each gender out of 690 patients included in the cohort, 
using a full factorial design as described in (Surowiec et al. 
2015) and in Supplementary Material. The main aim of the 
applied sample selection procedure was to select the sam-
ples that would uniformly span the space described by all 
available samples and personal and clinical parameters 
recorded for them.
2.2  Lipidomics analysis
Plasma was prepared through gel flotation of whole blood 
on site in Rwanda, snap frozen and transported in liquid 
nitrogen to Sweden, thawed once for aliquoting, frozen and 
stored in −80 °C until plasma lipids were extracted with 
modified Folch extraction and analysed with LCMS-QTOF 
as described in Supplementary Material. Six pooled plasma 
samples were analysed in parallell with the samples from 
patients in order to establish repeatability of the analytical 
procedure. The average relative standard deviation (RSD) 
for all the metabolites detected in the samples was 5.2%. 
This result combined with low average RSDs of nine inter-
nal standards from all samples (5.3%) proves the stability of 
the applied analytical procedure. Example total ion chroma-
tograms for each class of samples are presented at Fig. S1.
2.3  Compound identification
A targeted feature extraction of the acquired LCMS-QTOF 
data was performed using the Profinder™ software package, 
version B.06.00 and in-house retention time and mass spec-
tra library built from standards of pure compounds and from 
compounds that were identified with MS/MS based on the 
known lipid fragmentation patterns in the commercial lipid 
mixtures from Sigma–Aldrich (Stockholm, Sweden). After 
peak extraction, each compound was manually checked for 
accurate mass and retention time agreement with appropri-
ate standards from the library; peaks with bad characteristics 
(overloaded, noisy, not Gaussian etc.) were excluded from 
the analysis. Identification of the compounds was confirmed 
by comparison of their MS/MS spectra with MS/MS spec-
tra of relevant compounds from the library. We managed to 
identify 117 lipid molecules (Table S4). Examples MS/MS 
spectra for the compounds from main detected lipid classes 
(LPCs, PCs, TAGs and SMs) are presented at Fig. S2.
2.4  Data normalization
The peak areas representing the different lipid species were 
normalized using the areas from nine internal standards. 
These peaks were eluted during the entire chromatograph 
according to the following procedure. A principal compo-
nent analysis model with Unit Variance Scaling (without 
subtraction of the average, UVN) was calculated using the 
peak areas of the internal standards. The t1-score value 
from this model for each sample was used to normalize the 
resolved data by dividing the peak areas of each sample with 
the corresponding score value (Redestig et al. 2009).
2.5  Data processing and multivariate and univariate 
data analysis
Compound data was imported into the SIMCA software 
(version 14.0) from MKS Data Analytics Solutions (Umeå, 
Sweden) for multivariate analysis. The data was mean cen-
tred and scaled to unit variance. Principal component anal-
ysis (PCA) was used to obtain an overview of the variation 
in the data and to check for trends and outliers in the data 
and orthogonal partial least squares discriminant analysis 
(OPLS-DA®) was used to compare lipid profiles of different 
classes of samples. Seven-fold cross-validation was used 
for calculating the all models. Lipidomic profiles related 
to parasitaemia were obtained from p(corr) vectors in the 
OPLS models with parasitaemia values as Y and lipid lev-
els as X. In all cases maximally one orthogonal compo-
nent was allowed in the OPLS models to avoid the risk of 
over-fitting (Trygg and Wold 2002). The significance of a 
metabolite for classification in the OPLS-DA models was 
specified by calculating the 95% confidence interval for the 
loadings using jack-knifing (Efron and Gong 1983).
One-way ANOVA and two-tailed unequal variance 
t-test were done with MetaboAnalyst 3.0 tool suite (Xia 
and Wishart 2016) with the p value threshold equal 0.05. 
Two-tailed Pearson correlation coefficients (r) between 
parasitaemia values and lipid levels, and between p(corr) 
vectors from the OPLS models were calculated with 95% 
confidence interval using the statistical package built into 
GraphPad Prism 6 software (San Diego, CA, U.S.A.). The 
Pearson correlations between lipid levels and clinical and 
personal data were calculated using in-house script writ-
ten using the Anaconda Python distribution v. 3.5 (https://
continuum.io). The Pearson correlation coefficients and the 
corresponding p-value against the null-hypothesis of no 
correlation were calculated using functions from the SciPy 
library (http://www.scipy.org/). The results were plotted 
using the Matplotlib library (http://matplotlib.org/).
3  Results
3.1  Plasma lipid levels correlated to certain clinical 
parameters
We have correlated lipid levels in infected individuals 
to demographic and clinical characteristics of the study 
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patients. The results are presented as Fig. 1 and Fig. S3–S6. 
A limited number of significant correlative relationships 
were found between certain lipids and clinical parameters. 
Even-chain length lysophosphatidylcholines (Fig. 1), were 
significantly (p < 0.05) positively correlated with diar-
rhea and depth of breathing and negatively correlated with 
height, pulse rate, breathing rate and temperature of the 
patients. The remaining lipids showed positive correlation 
with temperature, although significant only for selected 
phosphatidylcholines and sphingomyelins. Another visible 
trend was the positive correlation of TAGs with height and 
weight of the patients; longer chain TAGs were also posi-
tively correlated with age. Triglycerides with higher carbon 
content were negatively correlated with blood glucose lev-
els of the patients.
3.2  Separation of cases and controls as well 
as characterization of lipid distribution using PCA
PCA was used to get an overview of all 117 identified 
lipid species from the 60 samples. One patient that 
belonged to the mild malaria group was found as an 
outlier on the PCA score plot and raw data revealed a 
lipid profile totally distinct from all other samples (data 
not shown). This sample was excluded from further 
analysis and a new PCA model was calculated (Fig. 2a; 
R2X(cum) = 0.803, Q2(cum) = 0.6, 6 components). Vis-
ible separation between infected and non-infected indi-
viduals could be seen along the two first components in 
the PCA score plot, with a shift from the upper left to 
the bottom right side of the PCA score plot that corre-
sponded to the differences between controls and cases 
respectively. This trend was not skewed by the samples 
representing patients with concomitant infections. In 
order to support the statement we have calculated the 
ROC curves based on the first two PCA scores, with the 
AUROC values 0.760 for the first score and 0.808 for the 
second one (Fig. S7), demonstrating that there was suffi-
cient (AUROC 0.6–0.7) to very good (AUROC 0.8–0.9) 
discrimination between studied groups of samples on 
the PCA score plot. Analysis of the corresponding load-
ing plot (Fig.  2b) showed an increased abundance of 
selected compounds from the TAG group and decreased 
abundance of all detected even-chain LPCs in infected 
Fig. 1  Correlation plot between 
clinical patient data and levels 
of lysophosphatidylcholines for 
infected individuals. The plot 
consists of two panels: (i) in 
the lower panel, the color and 
size of the circles correspond 
to the strength of the correla-
tion, with increasing circle size 
and color intensity indicating 
increasing correlation; shades 
of blue are used for negative 
correlations and shades of 
red for positive correlations, 
squares indicate correlations 
that were statistically significant 
(p-value < 0.05), and (ii) the 
upper panel shows the corre-
sponding Pearson’s correlation 
coefficients
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subjects as compared to the controls. No separation 
between mild and severe cases was visible in the plot.
3.3  OPLS‑DA case‑control models show hierarchy 
of lipid responses
OPLS-DA was used to investigate further differ-
ences between the studied sample groups. We calcu-
lated OPLS-DA models comparing severe cases and 
controls (R2X(cum) = 0.55, Q2(cum) = 0.62, CV-
ANOVA = 5.1 × 10−7 and 24% of variation in the data 
explained by predictive component) and mild cases 
and controls (R2X(cum) = 0.50, Q2(cum) = 0.72, CV-
ANOVA = 5.8 × 10−7 and 19% of variation in the data 
explained by predictive component). The performance 
of the OPLS-DA models to separate classes of samples 
based on predicted cross-validated vector is presented 
in Fig. S8 as scatter plots and in Fig.  3 in form of ROC 
curves. P(corr) values from these models together with 
metabolites significant according to the model are listed in 
Table S4. It was not possible to obtain an OPLS-DA model 
between severe and mild cases, hence these two groups 
of samples could not be differentiated based on their lipid 
profiles. A shared and unique structure (SUS) plot analy-
sis (Wiklund et  al. 2008) of p(corr) vectors from severe 
versus controls and mild versus controls models revealed 
high correlation of their lipid profiles (r = 0.96, Fig. S9). 
This means that lipid profiling can be used to model dif-
ferences between infected and not-infected individuals, but 
not between the malaria subgroups studied here. An OPLS-
DA model between infected and not infected patients was 
constructed (R2X(cum) = 0.50, Q2(cum) = 0.59, CV-
ANOVA = 6.0 × 10−10 and 21% of variation in the data 
explained by predictive component) to obtain a lipid profile 
Fig. 2  Lipidomic representation of patient groups. PCA score (a) 
and loading (b) plots on lipidomic data with samples colored accord-
ing to their respective group: a black dots signify severe malaria sam-
ples, gray dots mild malaria and blue signify controls. b Lipid spe-
cies on the loading plot are colored according to chemical classes. 
The separation of infected subjects and controls according to their 
lipidomic profiles is visualized in the plot; x axis—t[1] first score, y 
axis—t[2], second score
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related to the disease. The p(corr) values together with 
lipids significant for the model were compared with the pre-
vious models (Table S4). A combined lipid profile (p(corr)) 
where malaria cases and controls are compared is presented 
in Fig.  4. Significant metabolite fluctuations according to 
the jack-knifing confidence intervals are listed in Table S4. 
The entire profile was characterized by a majority of lipids 
showing elevated levels in infected individuals compared 
to controls, with exception of subgroup of TAGs and all 
LPCs. The main common feature of the TAGs subgroup 
compared to other species from this class was lower total 
length and a higher degree of saturation of the FA chains 
(average 46.3 vs. 53.8 carbon atoms and 1.1 versus 4.4 dou-
ble bonds per molecule for TAGs with negative and posi-
tive p(corr) value respectively), which are to some extent 
correlated with each other (more possible double bonds can 
exist in the longer fatty acid chain). This means that TAGs 
carrying fatty acid chains with predominantly 0–2 unsatu-
ration sites were present at lower levels in malaria cases, 
whereas TAGs with fatty acid chains with 3–12 unsatura-
tion sites were higher in infected individuals compared to 
controls. The highly unsaturated TAGs with longer chain 
lengths that exhibited a high abundance in infected indi-
viduals were also the ones that were the most significant 
TAGs for separation between malaria infected individuals 
and controls as shown by both univariate (Tables S5, S6) 
and multivariate analysis (significance according to jack-
knifing confidence intervals, Table S4).
3.4  Univariate analysis of differences 
between the studied groups of samples
Significance of the differences between the means of the 
groups was tested with one-way ANOVA followed by 
post-hoc Tukey’s HSD test (Table S5). Student’s t test was 
used to compare means of compound levels in infected 
individuals versus controls (Table  S6). Fifty-five com-
pounds were found to be significant according to the one-
way ANOVA (42 for mild-controls and severe-controls 
comparisons and 13 for severe-controls comparison only) 
and 62 for separation of all infected individuals from con-
trols according to the t test (p value < 0.05). Univariate 
analysis confirmed findings from the multivariate mod-
elling—a majority of lipids were present in significantly 
higher levels in the infected individuals, whereas LPCs 
were at significantly lower levels. Chain length and degree 
of saturation in TAGs were again identified as separators 
of infected individuals and controls. Triacylglycerides with 
longer fatty acid chains and higher degree of unsaturation 
were found at higher levels in infected individuals com-
pared to controls.
3.5  Lipid responses are inversely related 
to parasitaemia in comparison to case‑controls
Since parasitaemia is one way to estimate total parasite 
load we set out to investigate how this affects the plasma 
lipidome. In order to obtain a lipid profile connected to par-
asitaemia, an OPLS model was created with lipid levels as 
X matrix and parasitaemia values as Y. When we used all 
individuals with known parasitaemia scores (37 individu-
als from 41) the OPLS model, even though valid accord-
ing to cross-validation, had a Q2 value below zero and 
could not be used to generate a parasitaemia-related lipid 
profile. We could however see that the majority of samples 
from the mild class were not well predicted by the model. 
We found a low span of values within this class of sam-
ples (0.37–4.02), and no model could be created for mild 
samples only. Improved linearity was observed for samples 
from the severe group (0.1–26.62 parasitaemia range) with 
the 37% of variation explained by the predictive component 
of the OPLS model. The lipid profiles showed a reduction 
of the majority of lipids with higher parasitaemia values, 
with the exception being even-chain LPCs and TAGs with 
lower total carbon content and higher degree of saturation 
(average 53.0 vs. 43.5 carbon atoms and 3.8 vs. 0.8 double 
bonds per molecule for TAGs with negative and positive 
p(corr) value respectively). The lipid profile correlated to 
increased parasitaemia values for severe cases is presented 
in Fig. S10 and summarized in Table S4. As such, the pro-
file was reversely correlated (r = −0.86) with the profile 
obtained from the OPLS-DA model comparing the infected 
individuals and controls. This is visualized in a SUS plot in 
Fig. 5.
Univariate correlation analysis of each metabolite 
with parasitaemia revealed relationships that were sig-
nificant (p-value < 0.05) according to the set threshold 
Fig. 3  Lipid signature patterns as diagnostic separators. Diagnos-
tic performance of lipid profile signature for severe malaria (white 
squares; AUROC = 0.9180 to 1.012 at 95% CI, p < 0.0001) and 
mild malaria (black dots; AUROC = 0.9329 to 1.015 at 95% CI, 
p < 0.0001); values of cross-validated predictive vector (t[1]cv) from 
the OPLS-DA models were taken for the ROC curves calculation
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Fig. 4  Lipid profile of infected individuals. a Predictive loading vec-
tor (p(corr)) from the OPLS-DA model between subjects infected 
with malaria and controls; lipid species are colored according to their 
chemical classes; p(corr) values indicate if the metabolite is in higher 
or lower levels in infected individuals compared with controls. b Pre-
dictive loading vector with p(corr) values for triglycerides colored 
according to total carbon content of the triglyceride molecule. c Pre-
dictive loading vector with p(corr) values for triglycerides colored 
according to total number of non-saturated locations in the triglycer-
ide carbon chain
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(Table  S7). When all infected samples were considered, 
only phosphatidylethanolamine (34:0) demonstrated a sig-
nificant negative correlation with parasitaemia. When the 
severe group only was considered, two lipid metabolites 
(TAG(42:2) and TAG(42:1)), were positively correlated 
with parasitaemia and 16 exhibited a negative correlation. 
The mild cases alone did not show any lipid species with 
significant correlation to parasitaemia.
4  Discussion
The intricate fluctuation of metabolites in biological matri-
ces during acute infectious stress has yet to be extensively 
investigated. We present herein an in depth cross-sectional 
study of the lipid profiles in pediatric malaria patients.
All detected even chain length LPCs were at lower lev-
els in infected individuals compared to controls. The reduc-
tion was also body temperature dependent implying that, 
as seen in sepsis, the pyrogenic response plays a role in 
regulating the presence of LPCs in malaria. These species 
of lipids were also positively correlated with higher para-
sitaemia values. This means that even chain length LPCs 
were present at lower amounts in the malaria cases com-
pared with the healthy controls. Contra intuitively however, 
LPC levels increased with parasitaemia. LPCs are plasma 
lipids that are created from phospatidylcholines by action 
of phospholipase  A2 or by oxidation. They have been rec-
ognized as important cell signaling molecules, involved in 
wide range of physiological and pathophysiological pro-
cesses (Fukushima et al. 2001; Birgbauer and Chun 2006). 
They are major components of oxidized low-density lipo-
proteins (oxLDL) and were previously described to be 
important inflammatory mediators with recognized effects 
in multiple immune cell types and hence connected to 
innate and also adaptive immune responses (Jackson et al. 
2008; Kabarowski 2009). LPCs activate a number of sec-
ondary messengers by vast amount of signaling pathways 
as described in several reviews (Hla et al. 2001; Xu et al. 
2003; Gardell et  al. 2006; Torkhovskaya et  al. 2007; zu 
Heringdorf and Jakobs 2007). LPC levels are markedly 
decreased in sepsis and their lowered levels show strong 
predictive power for sepsis-related mortality (Drobnik 
et  al. 2003). In malarial infection intracellular activation 
of PLA-2 because of oxidative stress occurs in the infected 
red blood cells (Becker et  al. 2004). This would lead to 
higher LPC levels in the infected erythrocytes. However, it 
is not the case extracellularly in the peripheral circulation. 
Administration of LPC in experimental sepsis has been 
shown to protect mice against sepsis-induced lethality (Yan 
et al. 2004), most probably by enhancing bactericidal activ-
ity of neutrophils. Immunosuppression in sepsis is believed 
to be the major contributing factor in sepsis-induced mor-
tality (Hotchkiss and Karl 2003), and hence therapeutic 
action of LPC in sepsis can be attributed to its stimulatory 
effect on immune system (Kabarowski 2009). Since acute 
P. falciparum infection also induces an overwhelming acute 
phase response, it is possible that also in malaria adminis-
tration of LPCs could have therapeutic effects and therefore 
be used to support treatment. An increase of LPC levels 
with higher parasitaemia values would on the other hand 
point towards an increased activation of immune system 
with higher amount of parasites in the blood. Our findings 
point to the important role of LPCs during malaria infec-
tion and hence confirm involvement of these molecules in 
the acute phase response in malaria.
Fig. 5  Global representation of lipids correlated to parasitemia. 
Shared and Unique Structure plot of correlation vectors (p(corr)) 
from the OPLS-DA infected individuals versus controls model (X 
axis) and OPLS-parasitaemia model for severe cases (Y axis). The 
lipids species are colored according to chemical class
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LPC(17:0), the only odd chain LPC detected in our 
study, showed different behavior than other LPCs, with 
non-significant correlation with the disease and negative 
correlation to the parasitaemia values. Until recently it was 
believed that odd chain fatty acids in human plasma are 
mainly derived from food, but recent studies have showed 
that endogenous pathways of odd chain fatty acid biosyn-
thesis can be active in humans (Jenkins et al. 2015). There 
are also data showing that the P. falciparum apicoplast 
fraction contains low levels of the odd-chain fatty acid, 
C17:0, which could be synthesized by either the type II 
FAS complex or by fatty acid elongases using propionyl-
CoA instead of acetyl-CoA (Botté et al. 2013). More data 
is however needed to understand the role of odd chain fatty 
acids and their derivatives in the malaria infection.
We detected increased levels of a majority of all lipid 
species in infected individuals. This is in accordance with 
previous studies concerning the involvement of lipopro-
teins during the acute phase response. The response was 
most profound for TAGs with long-chain unsaturated FA, 
whereas shorter and more saturated species demonstrated 
a reverse pattern. This challenges our understanding of the 
acute phase response and the lipid release response. We 
show that in malaria infection the short chain TAGs are 
not included in the acute phase TAGs release. The TAGs 
response found in our study subjects has implications on 
cellular respiration and immunomodulation. A number of 
human and animal studies demonstrate that mitochondrial 
dysfunction significantly contribute to the development of 
sepsis-induced multi-organ failure, whereas a restoration of 
function is required for recovery (Haden et al. 2007; Har-
rois et  al. 2009). Hecker et  al. (Hecker et  al. 2014) found 
that carnitine-independent catabolism of short chain FA 
through β-oxidation restores mitochondrial respiration 
to the same extent as long-chain FA. The authors suggest 
that short chain FA may be beneficial and also preferential 
in cellular respiration during stress. Our findings suggest 
that either these short FA are consumed at a higher rate or 
are sequestered by the host. Furthermore studies of lipid 
emulsions in cell systems show that FA imbalance affects 
immune-cell composition and function (Mayer et al. 2003a, 
b; Cury-Boaventura et  al. 2006, 2008; Versleijen et  al. 
2008). Clinical trials have also indicated adverse effects of 
lipid emulsions rich in long-chain n-6 polyunsaturated fatty 
acids, at least in the critically ill patients. The supplemen-
tation of these FA resulted in an increased production of 
pro-inflammatory cytokines by mononuclear cells (Mayer 
et al. 2003a, b). We thus propose that the imbalance of long 
and short-chain FA contributes to the pathogenesis in acute 
malaria infection.
We hypothesize that the reversal of TAGs patterns 
in relationship to parasitaemia may be explained by the 
preferential parasite demand for long chain unsaturated 
TAGs in relation to short chain saturated TAGs. Our 
results clearly demonstrate that high parasitaemia scores 
correlates to low amounts of long unsaturated TAGs. 
The above profile appeared inverted when the cases and 
controls were compared. It is known since the 80s that 
P. berghei malarial infection results in an increase of the 
unsaturation level of triglycerides in the liver of mice 
(Deslauriers et al. 1988). This could speak for retention of 
unsaturated TAGs in the liver during infection and their 
subsequent release to the circulation. Although Plas-
modium can synthesize a number of FAs that are subse-
quently incorporated into parasite membranes, it is highly 
dependent on the host for the acquisition of specific lipid 
molecules (Mi-ichi et al. 2006). Using host lipid interme-
diates (mainly FAs and LPCs), the parasite is capable of 
extensive synthesis and remodeling of its own phospho-
lipids (Vial et  al. 2003). Cholesterol, which is essential 
for parasite intra-erythrocytic growth (Bansal et al. 2005) 
and infection (Samuel et al. 2001), is also fully obtained 
from the host. Compared to the host cell membrane the 
parasite outer membrane is enriched in phosphatidylcho-
line and phosphatidylethanolamine and depleted in cho-
lesterol and sphingomyelin. The cell membrane of eryth-
rocytes infected with parasite also undergoes remodeling 
and exhibits a decrease in the level of polyunsaturated 
phospholipids (Vial et  al. 2003). It has been shown that 
the different phases of the P. falciparum intra-erythro-
cytic life cycle are characterized by variations in lipid 
composition (Webster et al. 2009). Recent studies proved 
also that long chain unsaturated FAs are essential for 
parasite growth (Asahi et  al. 2005; Ramakrishnan et  al. 
2015), some of which have to be synthesized by the para-
sites themselves (Ramakrishnan et  al. 2012). The above 
relationship is actually beneficial to the parasite. Unsatu-
rated FAs including C18:1, C18:2, and C20:4 have been 
shown to activate protein kinase C (PKC) dependently on 
or independently of  Ca2+ and phospholipids (Murakami 
et  al. 1986), and might be involved in sustaining para-
site growth. Lipids are also necessary for the formation 
of hemozoin (Jackson et  al. 2004; Pisciotta et  al. 2007) 
and specifically unsaturated lipids were found to co-pre-
cipitate with ferriheme in the parasite’s acidic food vacu-
ole and dissolve sufficient monomeric ferriheme to allow 
polymerization (Fitch et al. 1999). A reduction of levels 
of TAGs with long chain FAs in patients with high para-
sitaemia could also result from increased consumption 
of these FAs in the acyl-carnitine pathway indicating a 
paucity of the substrates needed for beta-oxidation in the 
high parasitaemic patients. In our study we could not find 
statistically significant differences between severe and 
mild cases in the lipidome. There may be several reasons 
for this; first and foremost we had no non-survivors in the 
cohort. Langley et al. also found no differences between 
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sepsis, severe sepsis and septic shock survivors but found 
clear and reproducible differences between sepsis survi-
vors and non-survivors (Langley et al. 2013). The nutri-
tional status and proximity in time to feeding may also 
affect the outcome. However, one would expect statisti-
cally significant differences between the mild and severe 
cases since the severe cases have by definition difficulties 
in feeding, while the mild cases were less dehydrated and 
none of the patients with mild malaria were prostrated. 
Since our study is cross sectional, further investigation is 
needed to be able to fully appreciate the diversity of lipid 
responses in acute malaria infection.
5  Conclusions
In conclusion, the key findings from the experiments 
performed concerning full plasma lipidomics in malaria 
patients can be summarized as follows: (a) the host lipid 
response to malaria infection is dynamic and multi-
dimensional, with LPCs and TAGs levels responding 
inversely to disease and parasitaemia respectively; (b) the 
lipid perturbations are in themselves immunomodulatory 
and can affect energy turnover; (c) lipidomics may be 
used as tool to assess whole-body events in inflammation 
and acute infection by the use of plasma. It remains to see 
if the whole lipid acute phase response in other infections 
remain consistent with the response we have detailed 
herein.
Acknowledgements We want to thank Olivia Magara, Vincent 
Kayigire, Bob Kagoro, Tony Bazatsinda, Lisa Wiklund, Viktor Man-
berg, Ingela Ahlström, and Christine Kubwimana for assistance in 
the clinic, Rickard Sjögren for help with Python scripts and Ingela 
Nilsson for technical assistance. Special gratitude goes to Dr Charles 
Murego posthumously, who supported the team in Rwanda. This 
work was supported by the Swedish Research Council (Grant No. 
2011-6044 and 2013-8619), Molecular Infection Medicine Sweden 
(MIMS), the Erling Persson Foundation and the Jeansson Foundation. 
The Swedish Metabolomics Centre is acknowledged for support with 
LCMS-QTOF analysis.
Compliance with ethical standards 
Conflict of interest The authors declare that they have no competing 
financial interests.
Ethical approval The research was carried out according to The 
Code of Ethics of the World Medical Association (Declaration of Hel-
sinki). Ethical clearance was obtained from the Rwanda National Eth-
ics Committee RNEC (No: 279/RNEC/2010) and the Regional Ethical 
Committee in Umeå (No: 09-064).
Open Access This article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted 
use, distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
Alvarez, C., & Ramos, A. (1986). Lipids, lipoproteins, and apopro-
teins in serum during infection. Clinical Chemistry, 32, 142–145.
Asahi, H., Kanazawa, T., Hirayama, N., & Kajihara, Y. (2005). Inves-
tigating serum factors promoting erythrocytic growth of Plas-
modium falciparum. Experimental Parasitology, 109, 7–15. 
doi:10.1016/j.exppara.2004.10.002.
Bansal, D., Bhatti, H. S., & Sehgal, R. (2005). Role of cholesterol 
in parasitic infections. Lipids in Health and Disease, 4, 10. 
doi:10.1186/1476-511X-4-10.
Baptista, J. L., Vervoort, T., VanderStuyft, P., & Wery, M. (1996). 
Lipid plasma levels and Plasmodium falciparum infection in Sao 
Tome. Parasite-Journal De La Societe Francaise De Parasitolo-
gie, 3, 335–340.
Barcia, A. M., & Harris, H. W. (2005). Triglyceride-rich lipoproteins 
as agents of innate immunity. Clinical Infectious Diseases, 41, 
S498–S503. doi:10.1086/432005.
Becker, K., Tilley, L., Vennerstrom, J. L., Roberts, D., Rogerson, 
S., & Ginsburg, H. (2004). Oxidative stress in malaria para-
site-infected erythrocytes: Host-parasite interactions. Interna-
tional Journal for Parasitology, 34, 163–189. doi:10.1016/j.
ijpara.2003.09.011.
Birgbauer, E., & Chun, J. (2006). New developments in the biological 
functions of lysophospholipids. Cellular and Molecular Life Sci-
ences, 63, 2695–2701. doi:10.1007/s00018-006-6155-y.
Botté, C. Y., Yamaryo-Botté, Y., Rupasinghe, T. W. T., Mullin, K. A., 
MacRae, J. I., Spurck, T. P., et al. (2013). Atypical lipid compo-
sition in the purified relict plastid (apicoplast) of malaria para-
sites. Proceedings of the National Academy of Sciences, 110(18), 
7506–7511. doi:10.1073/pnas.1301251110.
Brown, H. A., & Marnett, L. J. (2011). Introduction to lipid bio-
chemistry, metabolism, and signaling. Chemical Reviews, 111, 
5817–6512.
Cabana, V. G., Siegel, J. N., & Sabesin, S. M. (1989). Effects of the 
acute phase response on the concentration and density distri-
bution of plasma-lipids and apolipoproteins. Journal of Lipid 
Research, 30, 39–49.
Cury-Boaventura, M. F., Gorjao, R., de Lima, T. M., Fiamoncini, 
J., Torres, R. P., Mancini-Filho, J., et al. (2008). Effect of olive 
oil-based emulsion on human lymphocyte and neutrophil death. 
Journal of Parenteral and Enteral Nutrition, 32, 81–87.
Cury-Boaventura, M. F., Gorjao, R., de Lima, T. M., Piva, T. M., 
Peres, C. M., et al. (2006). Toxicity of a soybean oil emulsion 
on human lymphocytes and neutrophils. Journal of Parenteral 
and Enteral Nutrition, 30, 115–123.
Deslauriers, R., Somorjai, R. L., Geoffrion, Y., Kroft, T., Smith, I. 
C., & Saunders, J. K. (1988). 1 H and 13 C NMR studies of 
tissue from normal and diseased mice. Analysis of T1 and T2 
relaxation profiles of triglycerides in liver. NMR in Biomedi-
cine, 1, 32–43.
Drobnik, W., Liebisch, G., Audebert, F. X., Frohlich, D., Gluck, T., 
Vogel, P., et  al. (2003). Plasma ceramide and lysophosphati-
dylcholine inversely correlate with mortality in sepsis patients. 
Journal of Lipid Research, 44, 754–761. doi:10.1194/jlr.
M200401-JLR200.
 J. Orikiiriza et al.
1 3
41 Page 12 of 13
Efron, B., & Gong, G. (1983). A leisurely look at the bootstrap, 
the jackknife, and cross-validation. American Statistician, 37, 
36–48. doi:10.2307/2685844.
Faucher, J. F., Ngou-Milama, E., Missinou, M. A., Ngomo, R., 
Kombila, M., & Kremsner, P. G. (2002). The impact of malaria 
on common lipid parameters. Parasitology Research, 88, 
1040–1043. doi:10.1007/s00436-002-0712-6.
Feingold, K. R., Staprans, I., Memon, R. A., Moser, A. H., Shi-
genaga, J. K., Doerrler, W., et  al. (1992). Endotoxin rapidly 
induces changes in lipid-metabolism that produce hypertri-
glyceridemia—low-doses stimulate hepatic triglyceride pro-
duction while high-doses inhibit clearance. Journal of Lipid 
Research, 33, 1765–1776.
Fitch, C. D., Cai, G. Z., Chen, Y. F., & Shoemaker, J. D. (1999). 
Involvement of lipids in ferriprotoporphyrin IX polymerization 
in malaria. Biochimica Et Biophysica Acta-Molecular Basis of 
Disease, 1454, 31–37. doi:10.1016/S0925-4439(99)00017-4.
Frankland, S., Adisa, A., Horrocks, P., Taraschi, T. F., Schnei-
der, T., Elliott, S. R., et  al. (2006). Delivery of the malaria 
virulence protein PfEMP1 to the erythrocyte surface requires 
cholesterol-rich domains. Eukaryotic Cell, 5, 849–860. 
doi:10.1128/Ec.5.5.849-860.2006.
Frankland, S., Elliott, S. R., Yosaatmadja, F., Beeson, J. G., Roger-
son, S. J., Adisa, A., et al. (2007). Serum lipoproteins promote 
efficient presentation of the malaria virulence protein PfEMP1 
at the erythrocyte surface. Eukaryotic Cell, 6, 1584–1594. 
doi:10.1128/Ec.00063-07.
Fukushima, N., Ishii, I., Contos, J. J. A., Weiner, J. A., & Chun, J. 
(2001). Lysophospholipid receptors. Annual Review of Phar-
macology and Toxicology, 41, 507–534. doi:10.1146/annurev.
pharmtox.41.1.507.
Gallin, J. I., Kaye, D., & Oleary, W. M. (1969). Serum lipids in 
infection. New England Journal of Medicine, 281, 1081–1086. 
doi:10.1056/Nejm196911132812001.
Gardell, S. E., Dubin, A. E., & Chun, J. (2006). Emerging medici-
nal roles for lysophospholipid signaling. Trends in Molecular 
Medicine, 12, 65–75. doi:10.1016/j.molmed.2005.12.001.
Gulati, S., Ekland, E. H., Ruggles, K. V., Chan, R. B., Jayabalasin-
gham, B., Zhou, B., et al. (2015). Profiling the essential nature 
of lipid metabolism in asexual blood and gametocyte stages of 
Plasmodium falciparum. Cell Host and Microbe, 18(3), 371–
381. doi:10.1016/j.chom.2015.08.003.
Haden, D. W., Suliman, H. B., Carraway, M. S., Welty-Wolf, K. E., 
Ali, A. S., Shitara, H., et al. (2007). Mitochondrial biogenesis 
restores oxidative metabolism during Staphylococcus aureus 
sepsis. American Journal of Respiratory and Critical Care 
Medicine, 176, 768–777. doi:10.1164/rccm.200701-161OC.
Harrois, A., Huet, O., & Duranteau, J. (2009). Alterations of 
mitochondrial function in sepsis and critical illness. Cur-
rent Opinion in Anaesthesiology, 22, 143–149. doi:10.1097/
ACO.0b013e328328d1cc.
Hecker, M., Sommer, N., Voigtmann, H., Pak, O., Mohr, A., Wolf, 
M., et  al. (2014). Impact of short- and medium-chain fatty 
acids on mitochondrial function in severe inflammation. 
Journal of Parenteral and Enteral Nutrition, 38, 587–594. 
doi:10.1177/0148607113489833.
Hla, T., Lee, M. J., Ancellin, N., Paik, J. H., & Kluk, M. J. (2001). 
Lysophospholipids—receptor revelations. Science, 294, 1875–
1878. doi:10.1126/science.1065323.
Hotchkiss, R. S., & Karl, I. E. (2003). Medical progress: The patho-
physiology and treatment of sepsis. New England Journal of 
Medicine, 348, 138–150. doi:10.1056/Nejmra021333.
Itoe, M. A., Sampaio, J. L., Cabal, G. G., Real, E., Zuzarte-Luis, 
V., March, S., et  al. (2014). Host cell phosphatidylcholine is a 
key mediator of malaria parasite survival during liver stage 
infection. Cell Host and Microbe, 16, 778–786. doi:10.1016/j.
chom.2014.11.006.
Jackson, K. E., Klonis, N., Ferguson, D. J. P., Adisa, A., Dogovski, 
C., & Tilley, L. (2004). Food vacuole-associated lipid bodies 
and heterogeneous lipid environments in the malaria parasite, 
Plasmodium falciparum. Molecular Microbiology, 54, 109–122. 
doi:10.1111/j.1365-2958.2004.04284.x.
Jackson, S. K., Abate, W., & Tonks, A. (2008). Lysophospholipid 
acyltransferases: Novel potential regulators of the inflam-
matory response and target for new drug discovery. Phar-
macology and Therapeutics, 119, 104–114. doi:10.1016/j.
pharmthera.2008.04.001.
Jenkins, B., West, J. A., & Koulman, A. (2015). A review of odd-
chain fatty acid metabolism and the role of pentadecanoic acid 
(C15:0) and heptadecanoic acid (C17:0) in health and disease. 
Molecules, 20, 2425–2444. doi:10.3390/molecules20022425.
Kabarowski, J. H. (2009). G2A and LPC: Regulatory functions 
in immunity. Prostaglandins and Other Lipid Mediators, 89, 
73–81. doi:10.1016/j.prostaglandins.2009.04.007.
Kafsack, B. F., & Llinas, C., M (2010). Eating at the table of another: 
metabolomics of host-parasite interactions. Cell Host and 
Microbe, 7, 90–99. doi:10.1016/j.chom.2010.01.008.
Khovidhunkit, W., Kim, M. S., Memon, R. A., Shigenaga, J. K., 
Moser, A. H., Feingold, K. R., et al. (2004). Effects of infection 
and inflammation on lipid and lipoprotein metabolism: Mecha-
nisms and consequences to the host. Journal of Lipid Research, 
45, 1169–1196. doi:10.1194/jlr.R300019-JLR200.
Kittl, E. M., Diridl, G., Lenhart, V., Neuwald, C., Tomasits, J., 
Pichler, H., et al. (1992). Hdl-cholesterol as a sensitive diagnos-
tic criterion in malaria. Wiener Klinische Wochenschrift, 104, 
21–24.
Lakshmanan, V., Rhee, K. Y., & Daily, J. P. (2011). Metabolomics 
and malaria biology. Molecular and Biochemical Parasitology, 
175, 104–111. doi:10.1016/j.molbiopara.2010.09.008.
Langley, R. J., Tsalik, E. L., van Velkinburgh, J. C., Glickman, S. 
W., Rice, B. J., Wang, C. P., et  al. (2013). An integrated clin-
ico-metabolomic model improves prediction of death in sep-
sis. Science Translational Medicine, 5, 195ra95. doi:10.1126/
scitranslmed.3005893.
Maréchal, E., Riou, M., Kerboeuf, D., Beugnet, F., Chaminade, P., & 
Loiseau, P. M. (2011). Membrane lipidomics for the discovery 
of new antiparasitic drug targets. Trends in Parasitology, 27(11), 
496–504. doi:10.1016/j.pt.2011.07.002.
Mayer, K., Gokorsch, S., Fegbeutel, C., Hattar, K., Rosseau, S., 
Walmrath, D., et  al. (2003a). Parenteral nutrition with fish oil 
modulates cytokine response in patients with sepsis. American 
Journal of Respiratory and Critical Care Medicine, 167, 1321–
1328. doi:10.1164/rccm.200207-674OC.
Mayer, K., Meyer, S., Reinholz-Muhly, M., Maus, U., Merfels, M., 
Lohmeyer, J., et al. (2003b). Short-time infusion of fish oil-based 
lipid emulsions, approved for parenteral nutrition, reduces mono-
cyte proinflammatory cytokine generation and adhesive interac-
tion with endothelium in humans. Journal of Immunology, 171, 
4837–4843.
Mi-ichi, F., Kita, K., & Mitamura, T. (2006). Intraerythrocytic Plas-
modium falciparum utilize a broad range of serum-derived fatty 
acids with limited modification for their growth. Parasitology, 
133, 399–410. doi:10.1017/S0031182006000540.
Murakami, K., Chan, S. Y., & Routtenberg, A. (1986). Protein-kinase-
C activation by Cis-fatty acid in the absence of  Ca2+ and phos-
pholipids. Journal of Biological Chemistry, 261, 5424–5429.
Navab, M., Anantharamaiah, G. M., & Fogelman, A. M. (2005). 
The role of high-density lipoprotein in inflammation. Trends 
in Cardiovascular Medicine, 15, 158–161. doi:10.1016/J.
Tcm.2005.05.008.
Lipid response patterns in acute phase paediatric Plasmodium falciparum malaria 
1 3
Page 13 of 13 41
O’Donnell, A., Fowkes, F. J., Allen, S. J., Imrie, H., Alpers, M. P., 
Weatherall, D. J., et al. (2009). The acute phase response in chil-
dren with mild and severe malaria in Papua New Guinea. Trans-
actions of the Royal Society of Tropical Medicine and Hygiene, 
103, 679–686. doi:10.1016/j.trstmh.2009.03.023.
Olszewski, K. L., Morrisey, J. M., Wilinski, D., Burns, J. M., Vaidya, 
A. B., Rabinowitz, J. D., et al. (2009). Host-parasite interactions 
revealed by Plasmodium falciparum metabolomics. Cell Host 
and Microbe, 5, 191–199. doi:10.1016/j.chom.2009.01.004.
Parola, P., Gazin, P., Patella, F., Badiaga, S., Delmont, J., & Brouqui, 
P. (2004). Hypertriglyceridemia as an indicator of the severity 
of falciparum malaria in returned travelers: A clinical retrospec-
tive study. Parasitology Research, 92, 464–466. doi:10.1007/
s00436-003-1012-5.
Pisciotta, J. M., Coppens, I., Tripathi, A. K., Scholl, P. F., Shuman, J., 
Bajad, S., et al. (2007). The role of neutral lipid nanospheres in 
Plasmodium falciparum haem crystallization. Biochemical Jour-
nal, 402, 197–204. doi:10.1042/Bj20060986.
Ramakrishnan, S., Docampo, M. D., MacRae, J. I., Pujol, F. M., 
Brooks, C. F., van Dooren, G. G., et al. (2012). Apicoplast and 
endoplasmic reticulum cooperate in fatty acid biosynthesis in 
apicomplexan parasite Toxoplasma gondii. Journal of Biological 
Chemistry, 287, 4957–4971. doi:10.1074/jbc.M111.310144.
Ramakrishnan, S., Docampo, M. D., MacRae, J. I., Ralton, J. E., 
Rupasinghe, T., McConville, M. J., et al. (2015). The intracellu-
lar parasite Toxoplasma gondii depends on the synthesis of long-
chain and very long-chain unsaturated fatty acids not supplied by 
the host cell. Molecular Microbiology, 97, 64–76. doi:10.1111/
mmi.13010.
Redestig, H., Fukushima, A., Stenlund, H., Moritz, T., Arita, M., 
Saito, K., et  al. (2009). Compensation for systematic cross-
contribution improves normalization of mass spectrometry 
based metabolomics data. Analytical Chemistry, 81, 7974–7980. 
doi:10.1021/ac901143w.
Samuel, B. U., Mohandas, N., Harrison, T., McManus, H., Rosse, 
W., Reid, M., et  al. (2001). The role of cholesterol and glyco-
sylphosphatidylinositol-anchored proteins of erythrocyte rafts 
in regulating raft protein content and malarial infection. Journal 
of Biological Chemistry, 276, 29319–29329. doi:10.1074/jbc.
M101268200.
Sengupta, A., Ghosh, S., Das, B. K., Panda, A., Tripathy, R., Pied, S., 
et al. (2016). Host metabolic responses to Plasmodium falcipa-
rum infections evaluated by 1 H NMR metabolomics. Molecular 
BioSystems, 12, 3324–3332. doi:10.1039/c6mb00362a.
Shears, M. J., MacRae, J. I., Mollard, V., Goodman, Ch, D., Sturm, 
A., Orchard, L. M., et  al. (2017). Characterization of the Plas-
modium falciparum and P. berghei glycerol 3-phosphate acyl-
transferase involved in FASII fatty acid utilization in the malaria 
parasite apicoplast. Cellular Microbiology, 19(1), e.12633. 
doi:10.1111/cmi.12633.
Surowiec, I., Orikiiriza, J., Karlsson, E., Nelson, M., Bonde, M., 
Kyamanwa, P., et  al. (2015). Metabolic signature profiling as a 
diagnostic and prognostic tool in pediatric Plasmodium falci-
parum malaria. Open Forum Infectious Diseases, 2, ofv062. 
doi:10.1093/ofid/ofv062.
Torkhovskaya, T. I., Ipatova, O. M., Zakharova, T. S., Kochetova, M. 
M., & Khalilov, E. M. (2007). Lysophospholipid receptors in 
cell signaling. Biochemistry-Moscow, 72, 125–131. doi:10.1134/
S0006297907020010.
Trygg, J., & Wold, S. (2002). Orthogonal projections to latent 
structures (O-PLS). Journal of Chemometrics, 16, 119–128. 
doi:10.1002/Cem.695.
Vance, D. E., & Vance J. E. (2008). Biochemistry of lipids, lipopro-
teins and membranes, 5th edn. Elsevier: Amsterdam.
Versleijen, M. W., Oyen, W. J., Roelofs, H. M., van Emst-de Vries, S. 
E., Willems, P. H., Jansen, J. B., et al. (2008). Immune function 
and leukocyte sequestration under the influence of parenteral 
lipid emulsions in healthy humans: A placebo-controlled crosso-
ver study. American Journal of Clinical Nutrition, 87, 539–547.
Vial, H. J., Eldin, P., Tielens, A. G. M., & van Hellemond, J. 
J. (2003). Phospholipids in parasitic protozoa. Molecular 
and Biochemical Parasitology, 126, 143–154. doi:10.1016/
S0166-6851(02)00281-5.
Visser, B. J., Wieten, R. W., Nagel, I. M., & Grobusch, M. P. 
(2013). Serum lipids and lipoproteins in malaria—a system-
atic review and meta-analysis. Malaria Journal, 12, 442–456. 
doi:10.1186/1475-2875-12-442.
Vo Duy, S., Besteiro, S., Berry, L., Perigaud, C., Bressolle, F., Vial, 
H. J., et al. (2012). A quantitative liquid chromatography tandem 
mass spectrometry method for metabolomic analysis of Plasmo-
dium falciparum lipid related metabolites. Analytica Chimica 
Acta, 739, 47–55. doi:10.1016/j.aca.2012.06.016.
Webster, G. T., De Villiers, K. A., Egan, T. J., Deed, S., Tilley, L., 
Tobin, M, J., et al. (2009). Discriminating the intraerythrocytic 
lifecycle stages of the malaria parasite using synchrotron FT-IR 
microspectroscopy and an artificial neural network. Analytical 
Chemistry, 81, 2516–2524. doi:10.1021/ac802291a.
Wendel, M., Paul, R., & Heller, A. R. (2007). Lipoproteins in inflam-
mation and sepsis. II. Clinical aspects. Intensive Care Medicine, 
33, 25–35. doi:10.1007/s00134-006-0433-x.
WHO (2010). Guidelines for the treatment of malaria, 2nd  Edn. 
Geneva: World Health Organization.
Wiklund, S., Johansson, E., Sjostrom, L., Mellerowicz, E. J., Edlund, 
U., Shockcor, J. P., et al. (2008). Visualization of GC/TOF-MS-
based metabolomics data for identification of biochemically 
interesting compounds using OPLS class models. Analytical 
Chemistry, 80, 115–122. doi:10.1021/Ac0713510.
Xia, J., & Wishart, D. S. (2016). Using metaboanalyst 3.0 for compre-
hensive metabolomics data analysis. Current Protocols in Bioin-
formatics, 55, 14.10.1–14.10.91. doi:10.1002/cpbi.11.
Xu, Y., Xiao, Y. J., Zhu, K., Baudhuin, L. M., Lu, J., Hong, G., et al. 
(2003). Unfolding the pathophysiological role of bioactive 
lysophospholipids. Current Drug Targets Immune Endocrine and 
Metabolic Disorders, 3, 23–32.
Yan, J. J., Jung, J. S., Lee, J. E., Lee, J., Huh, S. O., Kim, H. S., et al. 
(2004). Therapeutic effects of lysophosphatidylcholine in experi-
mental sepsis. Nature Medicine, 10, 161–167. doi:10.1038/
nm989.
zu Heringdorf, D. M., & Jakobs, K. H. (2007). Lysophospholipid 
receptors: Signalling, pharmacology and regulation by lysophos-
pholipid metabolism. Biochimica Et Biophysica Acta-Biomem-
branes, 1768, 923–940. doi:10.1016/j.bbamem.2006.09.026.
